The maturation process of lymphocytes and how Anktiva, an IL-15 superagonist, enhances these processes A comprehensive, step-by-step summary of the key processes in Immunology 2.0 and their potential to transform standard cancer care.

Why are lymphocytes often neglected in cancer treatment, and what changes are necessary?
huggenberg.substack.com/p/fundamenta...
#Immunotherapy #PrecisionMedicine #CancerResearch #NKcells #Lymphopenia #CARNK #immunosky

A regulatory pathway to establish a cancer therapy platform based on #Immunotherapy , avoiding #Lymphopenia caused by chemotherapy and radiation, with full patent protection. tinyurl.com/437xrx77
#immunology #PrecisionMedicine #CancerResearch #NKcells #Lymphopenia #CARNK #immunosky

MIT and Harvard Engineer Invisible CAR-NK Cells to Fight Cancer

MIT and Harvard engineered CAR‑NK cells that hide from the host immune system and, in humanized mice, eradicated lymphoma tumors and persisted for at least three weeks. Read more: getnews.me/mit-and-harvard-engineer... #carnk #cancertherapy #immunotherapy

CRISPR Uncovers Targets to Boost CAR-NK Cell Therapy CRISPR genome-wide screens reveal MED12, ARIH2, and CCNC as novel targets to boost persistence, efficacy of CAR-NK cell therapy.

New IO Paper Alert: CRISPR Screens Uncover New Targets to Boost CAR-NK Cell Therapy

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #IO #CRISPR #CARNKCellTherapy #CARNK

Hematology Weekly News – August 18th 2025 🔬🧬 Hematology Updates: Kamada FDA Approval, ITP Trial Success, AI in Hemophilia and More From the FDA greenlighting one of […] The post Hematology Weekly News – August 18th 2025 appeared first on LucidQuest Ventures.

FYI: LucidQuest Views >>> Hematology Weekly News – August 18th 2025 #News #BloodDisorders #anemia #RMAT #CARNK Comment below!

Hematology Weekly News – August 18th 2025 🔬🧬 Hematology Updates: Kamada FDA Approval, ITP Trial Success, AI in Hemophilia and More From the FDA greenlighting one of […] The post Hematology Weekly News – August 18th 2025 appeared first on LucidQuest Ventures.

ICYMI: LucidQuest Views >>> Hematology Weekly News – August 18th 2025 #News #BloodDisorders #anemia #RMAT #CARNK Comment below!

Hematology Weekly News – August 18th 2025 🔬🧬 Hematology Updates: Kamada FDA Approval, ITP Trial Success, AI in Hemophilia and More From the FDA greenlighting one of […] The post Hematology Weekly News – August 18th 2025 appeared first on LucidQuest Ventures.

LucidQuest Views >>> Hematology Weekly News – August 18th 2025 #News #BloodDisorders #anemia #RMAT #CARNK Comment below!

Derivation of ImmunityBio's Car-NK strategy
After AI research, a potential strategy for ImmunityBio's future NK-92 and CAR-NK platform can be inferred from several clues provided by three new AACR25 abstract posters.
#CARNK #immunology #NKcell #immunosky
Details:
cloud.hoststar.ch/s/FG546bHA6w...

CREM is a regulatory checkpoint of CAR and IL-15 signalling in NK cells - Nature The transcription factor CREM is a pivotal regulator of NK cell function, making CREM a valuable target to increase the efficacy of anticancer immunotherapies based on this cell population and chimeri...

I’m thrilled to share our work out now in Nature identifying CREM as a central intracellular checkpoin in #CARNK cells.

📄Link: nature.com/articles/s41...

Our story👇🏼

A pleasure to learn from Global Cell Therapy Leader Dr. Katy Rezvani of MD Anderson Cancer Center! She delivered a phenomenal Grand Rounds on the promise and clinical efficacy of NK CAR therapy. The future of cell therapy is truly exciting! 🔬✨ #CARNK #CellTherapy #MedicalInnovation

Anktiva as a lymphocyte rescue molecule: Unlocking the power of NK cells and T cells "One way to think about how Anktiva works is it is the first molecule, based on the package insert, that increases and proliferates the NK cells, the T cells, and the CD4+ and CD8+ T cells, without up...

New blood test routine:
Anemia —> Epogen
Neutropenia —> Neupogen
Lymphopenia —> Anktiva
#Immunotherapy #antibody_fusion_protein #NKcells #Lymphopenia #CARNK

#Anktiva mechanism of action

www.urologytimes.com/view/anktiva...

ImmunityBio Receives FDA RMAT Designation for ANKTIVA® and CAR-NK for the Reversal of Lymphopenia in Patients Receiving Standard-of-Care Chemotherapy/Radiotherapy and in Treatment of Multiply Relapsed... Regenerative Medicine Advanced Therapy (RMAT) designation follows clinical data of Absolute Lymphocyte Count (ALC) and significant Overall Survival (OS) correlations in QUILT trials across multiple tu...

Former blood test routine:
Anemia —> Epogen
Neutropenia —> Neupogen

New blood test routine:
Anemia —> Epogen
Neutropenia —> Neupogen
Lymphopenia —> Anktiva

#Immunotherapy #antibody_fusion_protein #NKcells #Lymphopenia #CARNK

ir.immunitybio.com/news-release...

From ex vivo to in vivo chimeric antigen T cells manufacturing: new horizons for CAR T-cell based therapy - Journal of Translational Medicine In the past decades, Chimeric Antigen Receptor (CAR)-T cell therapy has achieved remarkable success, leading to the approval of six therapeutic products for haematological malignancies. Recently, the ...

New article provides a fantastic overview of next-gen #InVivo #CARTcellTherapies, delivery systems, mfg process, possible drawbacks, and a future that might include #CARNK and #CARM. #CellandGeneTherapy #CARTcells #CellTherapyManufacturing

translational-medicine.biomedcentral.com/articles/10....